| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| FabiÅ¡Ãková M et al. | Total synthesis and the anticancer activity of (+)-spisulosine. | 2016 | Carbohydr. Res. | pmid:27693911 |
| Steiner R et al. | Elucidating the chemical structure of native 1-deoxysphingosine. | 2016 | J. Lipid Res. | pmid:27165858 |
| Duan J and Merrill AH | 1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma. | 2015 | J. Biol. Chem. | pmid:25947379 |
| Esaki K et al. | L-Serine Deficiency Elicits Intracellular Accumulation of Cytotoxic Deoxysphingolipids and Lipid Body Formation. | 2015 | J. Biol. Chem. | pmid:25903138 |
| Wei N et al. | Altered sphingoid base profiles in type 1 compared to type 2 diabetes. | 2014 | Lipids Health Dis | pmid:25305670 |
| Kowluru A | Deoxysphingolipids: β-cell, beware of these new kids on the block. | 2014 | Diabetes | pmid:24651803 |
| Zuellig RA et al. | Deoxysphingolipids, novel biomarkers for type 2 diabetes, are cytotoxic for insulin-producing cells. | 2014 | Diabetes | pmid:24379346 |
| Calder ED et al. | Preparation of anti-vicinal amino alcohols: asymmetric synthesis of D-erythro-sphinganine, (+)-spisulosine, and D-ribo-phytosphingosine. | 2013 | J. Org. Chem. | pmid:23795558 |
| Abad JL et al. | Straightforward access to spisulosine and 4,5-dehydrospisulosine stereoisomers: probes for profiling ceramide synthase activities in intact cells. | 2013 | J. Org. Chem. | pmid:23679346 |
| Byun HS et al. | Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells. | 2013 | Medchemcomm | pmid:24396570 |
| Xu K et al. | A highly anti-selective asymmetric Henry reaction catalyzed by a chiral copper complex: applications to the syntheses of (+)-spisulosine and a pyrroloisoquinoline derivative. | 2012 | Chemistry | pmid:22907874 |
| Massard C et al. | Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors. | 2012 | Invest New Drugs | pmid:22215532 |
| Vilar E et al. | A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors. | 2012 | Invest New Drugs | pmid:20820909 |
| Chen BS et al. | Diastereoselective synthesis and bioactivity of long-chain anti-2-amino-3-alkanols. | 2011 | Eur J Med Chem | pmid:21955681 |
| Garofalo K et al. | Oral L-serine supplementation reduces production of neurotoxic deoxysphingolipids in mice and humans with hereditary sensory autonomic neuropathy type 1. | 2011 | J. Clin. Invest. | pmid:22045570 |
| Scherer SS | The debut of a rational treatment for an inherited neuropathy? | 2011 | J. Clin. Invest. | pmid:22045569 |
| Rotthier A et al. | Characterization of two mutations in the SPTLC1 subunit of serine palmitoyltransferase associated with hereditary sensory and autonomic neuropathy type I. | 2011 | Hum. Mutat. | pmid:21618344 |
| Merrill AH | Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. | 2011 | Chem. Rev. | pmid:21942574 |
| Schöffski P et al. | Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies. | 2011 | Cancer Chemother. Pharmacol. | pmid:21465314 |
| Malik G et al. | Aziridines from intramolecular alkene aziridination of sulfamates: reactivity toward carbon nucleophiles. application to the synthesis of spisulosine and its fluoro analogue. | 2011 | J. Org. Chem. | pmid:21812488 |
| Bertea M et al. | Deoxysphingoid bases as plasma markers in diabetes mellitus. | 2010 | Lipids Health Dis | pmid:20712864 |
| Baird RD et al. | Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors. | 2009 | Mol. Cancer Ther. | pmid:19509256 |
| Sánchez AM et al. | Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation. | 2008 | Eur. J. Pharmacol. | pmid:18343365 |
| Pruett ST et al. | Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols. | 2008 | J. Lipid Res. | pmid:18499644 |
| Salcedo M et al. | The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway. | 2007 | Apoptosis | pmid:17191124 |
| Den Brok MW et al. | Compatibility and stability of the novel anticancer agent ES-285 x HCl formulated with 2-hydroxypropyl-beta-cyclodextrin in infusion devices. | 2006 | Pharmazie | pmid:16454201 |
| Faircloth G and Cuevas C | Kahalalide F and ES285: potent anticancer agents from marine molluscs. | 2006 | Prog. Mol. Subcell. Biol. | pmid:17153351 |
| Den Brok MW et al. | Pharmaceutical development of a parenteral lyophilised formulation of the investigational anticancer agent ES-285.HCl. | 2005 Jul-Aug | PDA J Pharm Sci Technol | pmid:16218203 |
| Stokvis E et al. | A more sensitive MS detector does not obviously lead to a more sensitive assay: experiences with ES-285. | 2004 | Biomed. Chromatogr. | pmid:15273982 |
| Yun JM et al. | Efficient synthesis of enantiomerically pure 2-acylaziridines: Facile syntheses of N-Boc-safingol, N-Boc-D-erythro-sphinganine, and N-Boc-spisulosine from a common intermediate. | 2003 | J. Org. Chem. | pmid:14510541 |
| Stokvis E et al. | Quantitative analysis of ES-285, an investigational marine anticancer drug, in human, mouse, rat, and dog plasma using coupled liquid chromatography and tandem mass spectrometry. | 2003 | J Mass Spectrom | pmid:12794877 |
| Maraschiello C et al. | Phenylisothiocyanate and dansyl chloride precolumn derivatizations for the high-performance liquid chromatography analysis of the antitumoral agent ES-285 in dog plasma. | 2003 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:12798159 |
| den Brok MW et al. | Development and validation of a liquid chromatography-ultraviolet absorbance detection assay using derivatisation for the novel marine anticancer agent ES-285 x HCl [(2S,3R)-2-amino-3-octadecanol hydrochloride] and its pharmaceutical dosage form. | 2003 | J Chromatogr A | pmid:14661748 |
| Cuadros R et al. | The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers. | 2000 | Cancer Lett. | pmid:10754202 |
| pmid: |
Spisulosine
Spisulosine is a lipid of Sphingolipids (SP) class. Spisulosine is associated with abnormalities such as Infection, Renal impairment and Lesion of brain. The involved functions are known as Gene Expression, Cell Cycle, Drug Kinetics, Signal Transduction and Cell Cycle Arrest. Spisulosine often locates in Body tissue, Microfilaments, Skin, Stress Fibers and Tissue specimen.
Cross Reference
Introduction
To understand associated biological information of Spisulosine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Spisulosine?
Spisulosine is suspected in Infection, Renal impairment, Lesion of brain and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Spisulosine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Spisulosine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Spisulosine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Spisulosine?
There are no associated biomedical information in the current reference collection.
What genes are associated with Spisulosine?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Spisulosine?
There are no associated biomedical information in the current reference collection.